US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 12.950
  • -0.190-1.45%
Close Dec 11 16:00 ET
  • 12.950
  • 0.0000.00%
Post 16:02 ET
644.50MMarket Cap-4.20P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
-100.71%-29.22M
-108.30%-10.19M
Net income from continuing operations
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Depreciation and amortization
--11K
--9K
--8K
----
----
--0
--0
--0
----
----
Other non cash items
-38.23%-2.71M
-43.64%-2.85M
-193.45%-2.51M
-957.78%-6.87M
-403.90%-2.07M
---1.96M
---1.98M
---855K
-194.88%-649K
---410K
Change In working capital
39.02%5.72M
243.71%10.83M
20,885.25%12.68M
-1,067.62%-7.47M
-332.46%-3.98M
1,663.88%4.11M
-866.16%-7.54M
-106.28%-61K
-81.10%772K
-142.31%-921K
-Change in receivables
110.50%23K
210.84%184K
144.07%119K
---355K
--300K
---219K
---166K
---270K
--0
--0
-Change in prepaid assets
190.91%2.73M
132.71%1.18M
344.22%4.16M
-325.45%-9.53M
30.84%-1.22M
-464.66%-3M
-7,248.98%-3.6M
-1,676.85%-1.7M
-480.31%-2.24M
-1,225.48%-1.77M
-Change in payables and accrued expense
-59.60%2.96M
351.11%9.47M
339.38%8.4M
-19.82%2.42M
-461.82%-3.06M
2,627.14%7.34M
-465.15%-3.77M
121.30%1.91M
-32.63%3.01M
-58.12%846K
Cash from discontinued investing activities
Operating cash flow
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
-100.71%-29.22M
-108.30%-10.19M
Investing cash flow
Cash flow from continuing investing activities
1,886.65%79.61M
147.93%7.74M
60.11%-55.95M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
-16.14M
-140.25M
-21.76M
50M
Net PPE purchase and sale
---37K
--0
---59K
----
----
--0
--0
--0
----
----
Net investment purchase and sale
1,887.57%79.64M
147.93%7.74M
60.15%-55.89M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
---16.14M
---140.25M
---21.76M
--50M
Cash from discontinued investing activities
Investing cash flow
1,886.65%79.61M
147.93%7.74M
60.11%-55.95M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
---16.14M
---140.25M
---21.76M
--50M
Financing cash flow
Cash flow from continuing financing activities
-100.54%-1K
73.84%-152K
-42.92%116.21M
58.76%203.25M
106.93%74K
132.80%184K
-100.49%-581K
1,596.85%203.57M
437.62%128.02M
-1.07M
Net common stock issuance
--0
89.67%-60K
-42.96%116.12M
12,561.02%202.99M
--0
--0
---581K
--203.57M
---1.63M
---1.07M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
444.46%129.65M
--0
Proceeds from stock option exercised by employees
-78.26%40K
--192K
--149K
--258K
--74K
--184K
--0
--0
--0
--0
Net other financing activities
---41K
---284K
---63K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.54%-1K
73.84%-152K
-42.92%116.21M
58.76%203.25M
106.93%74K
132.80%184K
-100.49%-581K
1,596.85%203.57M
437.62%128.02M
---1.07M
Net cash flow
Beginning cash position
-32.91%67.86M
-34.60%90.42M
-43.78%49.3M
722.56%87.7M
76.28%86.3M
-21.15%101.14M
759.69%138.25M
722.56%87.7M
656.71%10.66M
214.78%48.96M
Current changes in cash
298.23%29.42M
39.20%-22.56M
-18.66%41.11M
-149.84%-38.4M
-195.48%-37M
81.29%-14.84M
-133.08%-37.11M
832.74%50.55M
732.58%77.04M
892.35%38.75M
End cash Position
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.3M
-43.78%49.3M
76.28%86.3M
-21.15%101.14M
759.69%138.25M
722.56%87.7M
722.56%87.7M
Free cash flow
-163.90%-50.22M
-47.88%-30.15M
-50.28%-19.2M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
-100.71%-29.22M
-108.30%-10.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -163.71%-50.19M-47.88%-30.15M-49.82%-19.14M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M-100.71%-29.22M-108.30%-10.19M
Net income from continuing operations -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Depreciation and amortization --11K--9K--8K----------0--0--0--------
Other non cash items -38.23%-2.71M-43.64%-2.85M-193.45%-2.51M-957.78%-6.87M-403.90%-2.07M---1.96M---1.98M---855K-194.88%-649K---410K
Change In working capital 39.02%5.72M243.71%10.83M20,885.25%12.68M-1,067.62%-7.47M-332.46%-3.98M1,663.88%4.11M-866.16%-7.54M-106.28%-61K-81.10%772K-142.31%-921K
-Change in receivables 110.50%23K210.84%184K144.07%119K---355K--300K---219K---166K---270K--0--0
-Change in prepaid assets 190.91%2.73M132.71%1.18M344.22%4.16M-325.45%-9.53M30.84%-1.22M-464.66%-3M-7,248.98%-3.6M-1,676.85%-1.7M-480.31%-2.24M-1,225.48%-1.77M
-Change in payables and accrued expense -59.60%2.96M351.11%9.47M339.38%8.4M-19.82%2.42M-461.82%-3.06M2,627.14%7.34M-465.15%-3.77M121.30%1.91M-32.63%3.01M-58.12%846K
Cash from discontinued investing activities
Operating cash flow -163.71%-50.19M-47.88%-30.15M-49.82%-19.14M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M-100.71%-29.22M-108.30%-10.19M
Investing cash flow
Cash flow from continuing investing activities 1,886.65%79.61M147.93%7.74M60.11%-55.95M-637.50%-160.47M-116.18%-8.09M105.58%4.01M-16.14M-140.25M-21.76M50M
Net PPE purchase and sale ---37K--0---59K----------0--0--0--------
Net investment purchase and sale 1,887.57%79.64M147.93%7.74M60.15%-55.89M-637.50%-160.47M-116.18%-8.09M105.58%4.01M---16.14M---140.25M---21.76M--50M
Cash from discontinued investing activities
Investing cash flow 1,886.65%79.61M147.93%7.74M60.11%-55.95M-637.50%-160.47M-116.18%-8.09M105.58%4.01M---16.14M---140.25M---21.76M--50M
Financing cash flow
Cash flow from continuing financing activities -100.54%-1K73.84%-152K-42.92%116.21M58.76%203.25M106.93%74K132.80%184K-100.49%-581K1,596.85%203.57M437.62%128.02M-1.07M
Net common stock issuance --089.67%-60K-42.96%116.12M12,561.02%202.99M--0--0---581K--203.57M---1.63M---1.07M
Net preferred stock issuance --------------0----------------444.46%129.65M--0
Proceeds from stock option exercised by employees -78.26%40K--192K--149K--258K--74K--184K--0--0--0--0
Net other financing activities ---41K---284K---63K----------------------------
Cash from discontinued financing activities
Financing cash flow -100.54%-1K73.84%-152K-42.92%116.21M58.76%203.25M106.93%74K132.80%184K-100.49%-581K1,596.85%203.57M437.62%128.02M---1.07M
Net cash flow
Beginning cash position -32.91%67.86M-34.60%90.42M-43.78%49.3M722.56%87.7M76.28%86.3M-21.15%101.14M759.69%138.25M722.56%87.7M656.71%10.66M214.78%48.96M
Current changes in cash 298.23%29.42M39.20%-22.56M-18.66%41.11M-149.84%-38.4M-195.48%-37M81.29%-14.84M-133.08%-37.11M832.74%50.55M732.58%77.04M892.35%38.75M
End cash Position 12.72%97.27M-32.91%67.86M-34.60%90.42M-43.78%49.3M-43.78%49.3M76.28%86.3M-21.15%101.14M759.69%138.25M722.56%87.7M722.56%87.7M
Free cash flow -163.90%-50.22M-47.88%-30.15M-50.28%-19.2M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M-100.71%-29.22M-108.30%-10.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data